↓ Skip to main content

Caloric restriction or telmisartan control dyslipidemia and nephropathy in obese diabetic Zücker rats

Overview of attention for article published in Diabetology & Metabolic Syndrome, January 2014
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Caloric restriction or telmisartan control dyslipidemia and nephropathy in obese diabetic Zücker rats
Published in
Diabetology & Metabolic Syndrome, January 2014
DOI 10.1186/1758-5996-6-10
Pubmed ID
Authors

Eduardo J Lezcano, Pablo Iñigo, Ana M Larraga, Cristina Barranquero, Ignacio Gimenez, Jesús Osada

Abstract

The obese Zücker diabetic fatty male rat (ZDF:Gmi™-fa) is an animal model of type II diabetes associated with obesity and related metabolic disturbances like dyslipidaemia and diabetic nephropathy. In addition, diabetic dyslipidaemia has been linked to vascular and glomerular damage too. Dietary fat restriction is a current strategy to tackle obesity and, telmisartan, as a renoprotective agent, may mediate cholesterol efflux by activating PPARγ. To test the hypothesis that both therapeutical alternatives may influence dyslipidaemia and nephropathy in the ZDF rat, we studied their effect on development of diabetes.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 8%
Unknown 12 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 23%
Student > Master 3 23%
Other 2 15%
Professor 1 8%
Student > Ph. D. Student 1 8%
Other 1 8%
Unknown 2 15%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 31%
Agricultural and Biological Sciences 3 23%
Medicine and Dentistry 2 15%
Unspecified 1 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Other 1 8%
Unknown 1 8%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 November 2014.
All research outputs
#11,429,900
of 12,855,952 outputs
Outputs from Diabetology & Metabolic Syndrome
#335
of 390 outputs
Outputs of similar age
#159,154
of 190,884 outputs
Outputs of similar age from Diabetology & Metabolic Syndrome
#8
of 9 outputs
Altmetric has tracked 12,855,952 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 390 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,884 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one.